Proposed approval of the new active amlodipine besilate in the product Amodip Flavoured Tablets for Cats

This consultation closed on 22 May 2018.
Consultation period: 
24 April 2018 to 22 May 2018

The APVMA is considering an application for approval of the active amlodipine besilate and registration of the product Amodip Flavoured Tablets for Cats. The product is to be registered for use in the treatment of arterial hypertension in cats.

We invite comment from 24 April 2018 to 22 May 2018 on whether the application for active approval and registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

  • occupational health and safety
  • public health
  • chemistry and manufacture
  • residues in food
  • environmental safety
  • trade
  • efficacy and target crop safety.

For more information, see APVMA Gazette notice (page 36) from 24 April 2018.

Please send your written submission by email, post or fax to:

Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
P O Box 6182
Kingston ACT 2604
Phone: +61 2 6210 4701
Fax: +61 2 6210 4721
Email: enquiries@apvma.gov.au

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.